|© Natural Society|
Jan 31, 2013 | Natural Society | Anthony Gucciardi
Right now we stand on the forefront of intellectual battle against biotechnology giants such as Monsanto who seek to monopolize the food supply through the extensive use of their genetically modified organisms, but what about tomorrow? It’s crucial that we continue the fight against Monsanto and GMO ingredients within the food, but as many are busy campaigning against the visible roots of GMO technology, the unseen roots of the biotech industry have grown much deeper — deep enough to delay any debate over today’s biotech initiatives until tomorrow.
It’s a powerful technique to utilize within the media, and I will highlight the specific key points in how it is deployed. You see as we are hammering Monsanto day in and day out over their pollution of the seed supply, corporations like Dow AgroSciences are working overtime on separate and far more serious initiatives. Initiatives are being set in motion to extend genetic modification to the human body at large. And it’s no longer being done behind the scenes.
Drugs, Vaccines Grown in Crops
One such direction includes what is known as biopharmaceutical farming. which has already been done to the point in which it contaminated the traditional food supply. For starters, a biopharmaceutical crop is one that actually grows the components of certain drugs or vaccinations. This can include anything from widescale birth control and antidepressants to the latest vaccination being pushed on the public. In the case of the 2002 contamination that actually led to a criminal trial, a company known as ProdiGene decided to begin planting a ton of biopharmaceutical crops that contained ingredients for vaccinations like AIDS, diabates, and diarrhea.
These biopharmaceutical crops, as it turns out, were mixed with traditional crops and the farmers had no idea. Despite this fact along with a series of criminal charges and some bad press, ProdiGene declined to apologize. In fact, they continue to assert that biopharmaceutical crops are the answer. They were eventually hit with $500,000 in fines and some minor words from the USDA, but assert along with Dow AgroSciences that by 2014 they will manage to weasel in around $200 billion worth of biopharmaceutical farming. They even are claiming that 10% of the corn within the US will be biopharmaceutical by that time.